Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study

Authors :: San Miguel, Jesus Hungria, Vania T. M. Yoon, Sung-Soo and Beksac, Meral Dimopoulos, Meletios A. Elghandour, Ashraf and Jedrzejczak, Wieslaw Wiktor Guenther, Andreas Nakorn, Thanyaphong Na Siritanaratkul, Noppadol Schlossman, Robert L. and Hou, Jian Moreau, Philippe Lonial, Sagar Lee, Jae-Hoon and Einsele, Hermann Salwender, Hans Sopala, Monika Redhu, Suman Paul, Sofia Corrado, Claudia Binlich, Florence and Richardson, Paul G.
Publication Year :: 2014

Tools